Skip to content
Screener

Phibro Animal Health Corporation PAHC Q4 2025 Annual earnings

Reported August 27, 2025 · After market close

Revenue$378.7MBeat by $16.3M
EPS$0.57Beat by $0.05
Revenue estimate$362.4M
EPS estimate$0.52

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$379.4M
EPS estimate$0.77

Financials

Q4 2025

Income statement

See full
Revenue$378.7M+38.6%
Gross profit$110.0M+26.2%
Operating income$33.7M+83.1%
Net income$17.2M+2,190%
EPS (diluted)$0.43+2,050%

Balance sheet

See full
Cash & equivalents$68.0M-3.6%
Total debt$59.1M-12.0%
Total equity$285.7M+11.3%
Total assets$1.4B+38.6%

Cash flow

See full
Operating cash flow$21.3M-25.2%
CapEx$13.1M+0.5%
Free cash flow$8.1M-47.1%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$1B+47.8%
Enterprise value$995.1M+47.2%
P/E20.8×-260×
P/S0.8×+0.1×

Profitability

See full
Gross margin30.9%+0.1pp
Operating margin8.5%+3.3pp
Net margin3.7%+3.5pp
FCF margin3.2%-1.3pp

Returns & leverage

See full
Return on equity17.8%+16.9pp
Debt / equity0.2×-0.1×
Current ratio2.8×-0.2×

Segments

By product

See full
Medicated Feed Additives And Others$206.5M+77.0%
Mineral Nutrition$64.2M+3.4%
Nutritional Specialties$47.4M+10.6%
Vaccines$38.6M+20.6%
Performance Products$22.1M+12.7%

By geography

See full
Latin America And Canada$84.1M+19.8%
EMEA$57.6M+77.8%
Asia Pacific$35.0M+107%

By segment

See full
Mineral Nutrition$64.2M+3.4%
Performance Products$22.1M+12.7%

FAQ

When did Phibro Animal Health Corporation report Q4 2025 earnings?
Phibro Animal Health Corporation (PAHC) reported Q4 2025 earnings on August 27, 2025 after market close.
What were Phibro Animal Health Corporation's Q4 2025 revenue and EPS?
Phibro Animal Health Corporation reported revenue of $378.7M and eps of $0.57 for Q4 2025.
Did Phibro Animal Health Corporation beat estimates in Q4 2025?
Revenue beat the consensus estimate of $362.4M by $16.3M. EPS beat the consensus estimate of $0.52 by $0.05.
How did Phibro Animal Health Corporation's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 38.6% from $273.2M a year earlier and eps grew 39.0% from $0.41.
Where can I find Phibro Animal Health Corporation's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001558370-25-011778) and the 10-K periodic report (0001558370-25-011776) directly on SEC EDGAR. The filing index links above go to sec.gov.